Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 1-overview of extracorporeal membrane oxygenation
Sidebotham D, McGeorge A, McGuinness S, Edwards M, Willcox T, Beca J: Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 1-overview of extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth 23: 886-892, 2009.
Commentary: Successful combined use of the Impella Recover 2.5 device and intraaortic balloon pump support for cardiogenic shock after acute myocardial infarction
El Oakley R: Commentary: Successful combined use of the Impella Recover 2.5 device and intraaortic balloon pump support for cardiogenic shock after acute myocardial infarction. ASAIO J 56: 517-518, 2010.
Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis
McCarthy RE 3rd, Boehmer JP, Hruban RH, et al: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342: 690-695, 2000.
Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation
Kawashima D, Gojo S, Nishimura T, et al: Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J 57: 169-176, 2011.
Successful use of the Impella device in giant cell myocarditis as a bridge to permanent left ventricular mechanical support
Suradi H, Breall JA: Successful use of the Impella device in giant cell myocarditis as a bridge to permanent left ventricular mechanical support. Tex Heart Inst J 38: 437-440, 2011.
Clinical use of temporary percutaneous left ventricular assist devices
Froesch P, Martinelli M, Meier P, et al: Clinical use of temporary percutaneous left ventricular assist devices. Catheter Cardiovasc Interv 78: 304-313, 2011.